Submit Deal

GAMETO

HQ - New York

Summary

Gameto is a women's health biotechnology company advancing programs from a cell engineering platform developed with George Church's lab at Harvard Medical School.

Deals Overview

Total Deals2

Valued Deals2

Total Value£ 59 M

Avg. Deal Size£ 29 M

Market Context

Senior Management

Dina Radenkovic
CEO and Co-Founder
Martín Varsavsky
Co-Founder & Chairman
Kylie Jordan
Business Development and Investor Relations Associate

Sort

29 May 2024|United States|Biotechnology

Target: GAMETO

Bidder: TWO SIGMA VENTURES

5 Service Providers

2 Target | 3 Bidder

6 Dealmakers

3 Target | 3 Bidder

£ 25 M

Value

12 Aug 2025|United States|Biotechnology

Target: GAMETO

Bidder: BOLD CAPITAL PARTNERS

14 Service Providers

2 Target | 12 Bidder

16 Dealmakers

4 Target | 12 Bidder

£ 32 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy